Neuralink announced on Tuesday that it has finally opened enrollment for the first in-human study of its N1 brain-computer interface.
Per the company's announcement, the PRIME study "aims to evaluate the safety of our implant and surgical robot and assess the initial functionality of our BCI for enabling people with paralysis to control external devices with their thoughts.
, converting the analog electrical signals of our brains into digital signals that machines understand. The N1 system from Nueralink leverages a high-fidelity Utah Array of hair-thin probes that, unlike Synchron's Stentrode, must be installed via robotic keyhole surgery .
Neuralink has been working on the N1 system since 2017, one of the first companies in the industry to begin publicly developing a commercial BCI.
France Dernières Nouvelles, France Actualités
Similar News:Vous pouvez également lire des articles d'actualité similaires à celui-ci que nous avons collectés auprès d'autres sources d'information.
Neuralink is recruiting subjects for the first human trial of its brain-computer interfaceNeuralink plans for the study to take six years and wants to test every part of its system — including the robot used to implant it.
Lire la suite »
Musk's Neuralink to start human trial for brain implant chipBillionaire entrepreneur Elon Musk's brain-chip startup Neuralink said on Tuesdaythat it has received approval from an independent review board to start the first human trial of its brain implant for paralysis patients.
Lire la suite »
Everything We Know About Neuralink’s Brain Implant TrialElon Musk’s neurotech startup announced that it is now seeking patients with paralysis to test a brain-computer interface.
Lire la suite »